GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Renergen Ltd (OTCPK:RGNNF) » Definitions » COGS-to-Revenue

RGNNF (Renergen) COGS-to-Revenue : 0.00 (As of Feb. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Renergen COGS-to-Revenue?

Renergen's Cost of Goods Sold for the six months ended in Feb. 2025 was $0.00 Mil. Its Revenue for the six months ended in Feb. 2025 was $0.00 Mil.

Renergen's COGS to Revenue for the six months ended in Feb. 2025 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Renergen's Gross Margin % for the six months ended in Feb. 2025 was N/A%.


Renergen COGS-to-Revenue Historical Data

The historical data trend for Renergen's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renergen COGS-to-Revenue Chart

Renergen Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only 1.48 1.29 0.72 1.24 -

Renergen Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.68 3.79 1.16 -

Renergen COGS-to-Revenue Calculation

Renergen's COGS to Revenue for the fiscal year that ended in Feb. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1.888 / 1.522
=1.24

Renergen's COGS to Revenue for the quarter that ended in Feb. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renergen  (OTCPK:RGNNF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Renergen's Gross Margin % for the six months ended in Feb. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Renergen COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Renergen's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Renergen Business Description

Traded in Other Exchanges
Address
25 Minerva Avenue, Sandton Gate, Glenadrienne, Sandton, ZAF, 2196
Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.

Renergen Headlines

No Headlines